StonvexLoading…
StonvexCore line items from OSK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.42B | $10.73B | $9.66B | $8.28B |
Operating Income | $939.50M | $1.01B | $837.60M | $372.30M |
Net Income | $647.00M | $681.40M | $598.00M | $173.90M |
EPS (Diluted) | $10.02 | $10.35 | $9.08 | $1.14 |
Total Assets | $10.07B | $9.42B | $9.13B | $7.73B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $479.80M | $204.90M | $125.40M | $805.90M |
Free Cash Flow OCF − CapEx | $618.00M | $269.10M | $274.30M | $331.80M |
Shares Outstanding | 62.59M | 64.60M | 65.47M | 65.47M |